TY - JOUR
T1 - Cost of illness (COI) of type-II diabetes mellitus in Shillong, Meghalaya
AU - Khongrangjem, T.
AU - Phadnis, Sameer
AU - Kumar, Sumit
N1 - Publisher Copyright:
© 2018, Research Society for Study of Diabetes in India.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - This study aimed at contributing to the evidence base of economic burden caused due to type-II DM. The data were obtained from the 158 diabetics from the three tertiary hospitals in Shillong, Meghalaya, during January–March 2017 with the use of a semi-structured questionnaire. The information received was cross-checked with the medical records from the finance department. Patients comprised of 86 (54.4%) females and 72 (45.6%) males. The individuals under the age group of 56–65 were 49 (31%). The total median cost of illness per month was Rs. 5375 (2524–18,968) which was made up of 70.92% direct cost and 29.08% indirect cost. 58.2% respondents used their savings for getting treatment. The cost of care is high and comparable to cost in other countries. An improved understanding of COI of type-II DM will help in informing and motivating the policy and health decision makers which will reduce the national burden of this disease.
AB - This study aimed at contributing to the evidence base of economic burden caused due to type-II DM. The data were obtained from the 158 diabetics from the three tertiary hospitals in Shillong, Meghalaya, during January–March 2017 with the use of a semi-structured questionnaire. The information received was cross-checked with the medical records from the finance department. Patients comprised of 86 (54.4%) females and 72 (45.6%) males. The individuals under the age group of 56–65 were 49 (31%). The total median cost of illness per month was Rs. 5375 (2524–18,968) which was made up of 70.92% direct cost and 29.08% indirect cost. 58.2% respondents used their savings for getting treatment. The cost of care is high and comparable to cost in other countries. An improved understanding of COI of type-II DM will help in informing and motivating the policy and health decision makers which will reduce the national burden of this disease.
UR - https://www.scopus.com/pages/publications/85063001314
UR - https://www.scopus.com/inward/citedby.url?scp=85063001314&partnerID=8YFLogxK
U2 - 10.1007/s13410-018-0636-z
DO - 10.1007/s13410-018-0636-z
M3 - Article
AN - SCOPUS:85063001314
SN - 0973-3930
VL - 39
SP - 201
EP - 205
JO - International Journal of Diabetes in Developing Countries
JF - International Journal of Diabetes in Developing Countries
IS - 1
ER -
